Simplification to dual therapy (atazanavir/ritonavir¿+¿lamivudine) versus standard triple therapy [atazanavir/ritonavir¿+¿two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study) Academic Article 2017 uri icon

authors

  • Pérez Molina JA
  • Troya J
  • Mariño A
  • Antela A
  • RAMOS RINCON, JOSE MANUEL
  • Navarro J
  • Esteban H
  • Moreno S
  • GeSIDA 7011 Study Group
  • Rubio R
  • Rivero A
  • Pascuau J
  • Suárez-Lozano I
  • Riera M
  • Estébanez M
  • Palacios R
  • Sanz-Moreno J

publication date

  • 2017